XML 14 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenues $ 1,149,342 $ 434,507
Cost of revenue 587,464 341,042
Gross profit 561,878 93,465
Operating expenses:    
Selling and marketing 610,662 279,727
Research and development 49,667 44,702
General and administrative 936,960 737,681
Amortization and depreciation 127,665 145,488
Total operating expenses 1,724,954 1,207,598
Operating loss (1,163,076) (1,114,133)
Other income (expense):    
Unrealized gain on derivative liabilities 0 310,773
Unrealized gain on marketable securities 228 0
Interest income 237 164
Total other income 465 310,937
Net loss (1,162,611) (803,196)
Dividends on Series A Convertible preferred stock (13,750) (20,000)
Net loss available to common stockholders $ (1,176,361) $ (823,196)
Net loss per common share-basic and diluted $ (0.01) $ (0.01)
Weighted average common shares outstanding-basic and diluted 161,664,077 111,884,024